Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathies

19 Sept 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Hemoglobinopathies and Related Disorders
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37729905
DOI: 10.1016/j.ymthe.2023.09.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathiesPMID 37729905Read ↗

Editing human hematopoietic stem cells: advances and challengesSemantic proximity Read ↗

Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo ProspectsSemantic proximity Read ↗

Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.Semantic proximity Read ↗

Recent advance on genome editing for therapy of β-hemoglobinopathies.Semantic proximity Read ↗

Therapeutic base editing of human hematopoietic stem cellsSemantic proximity Read ↗

Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challengesSemantic proximity Read ↗

Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapySemantic proximity Read ↗

Genome Editing for β-Hemoglobinopathies: Advances and ChallengesSemantic proximity Read ↗

Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene EditingSemantic proximity Read ↗

The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challengesSemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

Therapy Development by Genome Editing of Hematopoietic Stem CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.